journal article·2025-12-10

Natural Ginger-Derived Exosomes as Effective Therapeutics for Glioblastoma

Shiyu Wang, Dongya Zhang, Meng Zheng, Yan Zou, Bingyang Shi

Nano Letters· Volume 25· Issue 49
Publisher page

Abstract

Despite significant therapeutic advances with chemotherapy and immunotherapy in some solid tumors, clinical outcomes for glioblastoma multiform (GBM) remain suboptimal. Owing to their high yield, easy accessibility and cost-effectiveness, plant-derived extracellular vehicles (EVs) have become attractive platforms for biomedical uses. Our study shows that fully natural ginger-derived exosomes (GEXO) effectively inhibited GBM progression through dual mechanisms: (a) direct activation of apoptotic pathways in GBM cells, and (b) induction of immunogenic cell death (ICD) that transforms dead tumor cells into endogenous vaccines. Mechanistically, GEXO demonstrated superior blood-brain barrier (BBB) penetration through clathrin-, caveolin- and macropinocytosis-mediated transcytosis, followed by tumor-specific accumulation via exocytosis. Transcriptomic analysis revealed that GEXO promoted an immunogenic shift in dying GBM cells, enhancing dendritic cell maturation and cytotoxic T-cell responses. In orthotopic GL261 and CT2A models, GEXO significantly prolonged survival without observable toxicity. The natural GEXO platform represents a promising, biosafe strategy with clinical potential for refractory GBM.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Immune cells in cancer · Ginger and Zingiberaceae research · Extracellular vesicles in disease

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Critical Care Medicine and Department of Emergency Medicine

The First Affiliated Hospital of Zhengzhou University

International Joint Centre for Biomedical Innovation, Henan Key Laboratory of Brain Targeted Bio-nanomedicine, School of Life Sciences, Henan University, Jing Ming Avenue, Kaifeng, Henan 475004, P. R. China

School of Biomedical Engineering

University of Technology Sydney

Funding

Natural Science Foundation of Henan Province · China Postdoctoral Science Foundation · National Natural Science Foundation of China · Henan University

References (49)

Show source-provided references
1. 10.1200/JCO.2017.73.011910.1200/JCO.2017.73.0119 ↗
2. 10.1093/neuonc/noad10710.1093/neuonc/noad107 ↗
3. 10.1016/j.phrs.2021.10578010.1016/j.phrs.2021.105780 ↗
4. 10.1200/JCO.22.0178510.1200/JCO.22.01785 ↗
5. 10.1093/neuonc/noae07310.1093/neuonc/noae073 ↗
6. 10.1093/neuonc/noac209.12510.1093/neuonc/noac209.125 ↗
7. 10.3322/caac.2161310.3322/caac.21613 ↗
8. 10.1001/jama.2023.002310.1001/jama.2023.0023 ↗
9. 10.1016/S1470-2045(09)70025-710.1016/S1470-2045(09)70025-7 ↗
10. 10.1007/s11060-018-2879-410.1007/s11060-018-2879-4 ↗
11. 10.1021/acsnano.4c0590610.1021/acsnano.4c05906 ↗
12. 10.1038/s41556-018-0250-910.1038/s41556-018-0250-9 ↗
13. 10.1126/science.aau697710.1126/science.aau6977 ↗
14. 10.1016/j.cell.2016.01.04310.1016/j.cell.2016.01.043 ↗
15. 10.1016/j.ajps.2021.05.00610.1016/j.ajps.2021.05.006 ↗
16. 10.1038/nrm.2017.12510.1038/nrm.2017.125 ↗
17. 10.1039/D3MH01030A10.1039/D3MH01030A ↗
18. 10.1039/D3TB02752J10.1039/D3TB02752J ↗
19. 10.1002/ptr.782810.1002/ptr.7828 ↗
20. 10.26599/NBE.2025.929011510.26599/NBE.2025.9290115 ↗
21. 10.1186/s12951-022-01421-w10.1186/s12951-022-01421-w ↗
22. 10.1038/s41598-021-93876-410.1038/s41598-021-93876-4 ↗
23. 10.1002/adma.20230418710.1002/adma.202304187 ↗
24. 10.1038/s41565-024-01722-110.1038/s41565-024-01722-1 ↗
25. 10.1186/s13020-024-00969-z10.1186/s13020-024-00969-z ↗
26. 10.3390/foods806018510.3390/foods8060185 ↗
27. 10.1155/2012/27865210.1155/2012/278652 ↗
28. 10.1093/carcin/bgt36510.1093/carcin/bgt365 ↗
29. 10.1016/j.biomaterials.2016.06.01810.1016/j.biomaterials.2016.06.018 ↗
30. 10.1021/acs.bioconjchem.4c0030010.1021/acs.bioconjchem.4c00300 ↗
31. 10.1126/science.110614810.1126/science.1106148 ↗
32. 10.1016/j.bbamcr.2011.03.01310.1016/j.bbamcr.2011.03.013 ↗
33. 10.1016/S0014-5793(03)00494-010.1016/S0014-5793(03)00494-0 ↗
34. 10.3390/molecules2302038410.3390/molecules23020384 ↗
35. 10.1038/s41467-023-40280-310.1038/s41467-023-40280-3 ↗
36. 10.1038/nrc338010.1038/nrc3380 ↗
37. 10.1002/smtd.20230020410.1002/smtd.202300204 ↗
38. 10.1002/EXP.2024027510.1002/EXP.20240275 ↗
39. 10.1016/j.jconrel.2017.09.01910.1016/j.jconrel.2017.09.019 ↗
40. 10.1093/neuonc/noab196.40310.1093/neuonc/noab196.403 ↗
41. 10.1016/j.cell.2016.12.02210.1016/j.cell.2016.12.022 ↗
42. 10.1016/j.immuni.2023.09.00510.1016/j.immuni.2023.09.005 ↗
43. 10.1002/adma.20190049910.1002/adma.201900499 ↗
44. 10.1038/s41577-019-0210-z10.1038/s41577-019-0210-z ↗
45. 10.1021/acsnano.4c0801410.1021/acsnano.4c08014 ↗
46. 10.1038/nri.2015.310.1038/nri.2015.3 ↗
47. 10.1038/s41571-021-00588-910.1038/s41571-021-00588-9 ↗
48. 10.1093/neuonc/noab00110.1093/neuonc/noab001 ↗
49. 10.1186/s12943-022-01612-x10.1186/s12943-022-01612-x ↗